Tianjin, China – July 28, 2022 – Genobio Pharmaceutical Co., Ltd, a wholly-owned subsidiary of Era Biology Group, which is a leader and pioneer of invasive fungal disease diagnostic field since 199...
Era Biology will host a global live webinar on November 29th 2022 22:00 (GMT +08:00). The webinar will talk about complete solutions for aspergillus galactomannan tests.
Aspergillus is often not sp...
(1,3)-β-D-Glucan is a component of the cell walls of many fungal organisms. Scientists investigate the feasibility of the BG assay and its contribution to early diagnosis of different types of inva...
Day 2 at ISHAM 2022
New Delhi, India – September 21, 2022 – Genobio with Indian local Partner Bio-State is participating 21th congress of the International Society for Human and Animal Mycology (IS...
FACIS Successfully Approved by Health Canada
We are glad to announce that the Full-Automatic Chemiluminescence Immunoassay System (FACIS), with its adaptable reagents the Aspergillus Galactomannan ...
These series of methods are assays by utilizing specific viral antigen to detect antibodies in patients’ serum, including IgM antibodies detection and IgG antibodies measurement. The IgM antibodies...